Skip Navigation LinksHome > December 2013 - Volume 113 - Issue 12 > New Integrase Strand Transfer Inhibitor Approved To Treat HI...
AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000438862.37283.a8
Drug Watch

New Integrase Strand Transfer Inhibitor Approved To Treat HIV-1

Aschenbrenner, Diane S. MS, RN

Collapse Box

Abstract

* A new drug, Dolutegravir (Tivicay), has been approved to treat HIV-1 infection in both treatment-naïve patients and those who have received prior therapy against HIV infection.

* Possible serious adverse effects of the drug include hypersensitivity and abnormal liver function if the patient is coinfected with hepatitis B or hepatitis C.

© 2013 Lippincott Williams & Wilkins. All rights reserved.

Login